Structure-Based Identification Of Telomerase Inhibitors From Andrographis Paniculata
International Journal of Drug Delivery Technology · 09.04.2026 · 16 (6s)
DOI: 10.25258/ijddt.16.6s.99 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Drug Delivery Technology, online erschienen am 09.04.2026. Verfasst von Quan Ke Thai und 3 weiteren Autor:innen.
Abstract (Originalsprache)
Elevated telomerase expression is a hallmark of many human malignancies. Targeting telomerase represents a promising therapeutic strategy, as it is largely absent in normal cells. However, the limitations and side effects of synthetic chemical inhibitors remain a challenge for sustained treatment. Consequently, the exploration of alternative remedies derived from medicinal plants, particularly as combination therapies, may help minimize adverse effects. Andrographis paniculata (AP) has long been employed in traditional medicine for cancer treatment. Among its constituents, Andrographolide is recognized as the principal compound underlying its anticancer activity. Nevertheless, the mechanism by which Andrographolide and its derivatives modulate telomerase activity has not been clearly elucidated. In this study, we screened Andrographolide and its derivatives from AP for their ability to bind the telomerase pocket using molecular docking and molecular dynamics simulations. Simulation results over 200 ns revealed that Andrographolide and two derivatives, LTS0109188 and LTS0004521, established stable and effective interactions with telomerase. Binding affinity evaluation through free energy analyses indicated that these compounds exhibited stronger affinity than the reference inhibitor BIBR1532. Accordingly, we report that Andrographolide, LTS0109188, and LTS0004521 may inhibit telomerase activity in a manner comparable to BIBR1532. Furthermore, pharmacological profiling demonstrated that these compounds fulfill most drug-likeness criteria, supporting their suitability for oral drug development. Toxicity assessment and anticancer bioactivity prediction further highlighted the potential of Andrographolide, LTS0109188, and LTS0004521 as promising candidates for cancer therapy.
Zitieren
APA
Thai, Q. K., Huynh, P., Nguyen, B., & Ngoc, P. N. (2026). Structure-Based Identification Of Telomerase Inhibitors From Andrographis Paniculata. International Journal of Drug Delivery Technology, 16(6s). https://doi.org/10.25258/ijddt.16.6s.99
Vancouver
Thai QK, Huynh P, Nguyen B, Ngoc PN. Structure-Based Identification Of Telomerase Inhibitors From Andrographis Paniculata. International Journal of Drug Delivery Technology. 2026;16(6s). doi:10.25258/ijddt.16.6s.99
BibTeX
@article{Thai2026,
author = {Thai, Quan Ke and Huynh, Phuoc and Nguyen, Ba-Hai and Ngoc, Phuong Nguyen},
title = {Structure-Based Identification Of Telomerase Inhibitors From Andrographis Paniculata},
journal = {International Journal of Drug Delivery Technology},
year = {2026},
volume = {16},
number = {6s},
doi = {10.25258/ijddt.16.6s.99}
}
EUVIMED